Where will we be in 12 months time?, page-15

Hear me out....

Expected sales year 2 are at least 300,000 units based on the japanese market penetration ( That is less than 1% of the market seeking treatment in USA)
Or in other words, 226 million AUD in profit , based on 300,000 unit sales in america ( or around only 25,000 patients, from 3,700,000 seeking treatment )
or about 4.5 billion AUD market cap..... with under 1% market penetration.... and PE 20:1

PE ain't going to be 20:1 when this gets approved, it will be a lot higher ( it already is ), but penetration will not be stuck less than 1%, should get at least 5%, but won't know until after approval in 6 weeks

So I think my range of 6 cents to $4 is pretty reasonable
$2 is 20:1 PE with 25,000 patients treated ( same as Japan in year 2 )

Let see